Compounds > 3,3',4,5'-tetrahydroxystilbene
Page last updated: 2024-08-16

3,3',4,5'-tetrahydroxystilbene and Acute Promyelocytic Leukemia

3,3',4,5'-tetrahydroxystilbene has been researched along with Acute Promyelocytic Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernhaus, A; Fritzer-Szekeres, M; Graser, G; Grusch, M; Horvath, Z; Jaeger, W; Ozsvar-Kozma, M; Pemberger, M; Saiko, P; Savinc, I; Szekeres, T1
Bertagnolo, V; Brugnoli, F; Capitani, S; Grassilli, S; Lambertini, E; Marchisio, M; Miscia, S; Piva, R; Varin-Blank, N1
Bavelloni, A; Bertagnolo, V; Brugnoli, F; Capitani, S; Carini, C; Mischiati, C; Sereni, A1

Other Studies

3 other study(ies) available for 3,3',4,5'-tetrahydroxystilbene and Acute Promyelocytic Leukemia

ArticleYear
Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
    International journal of oncology, 2008, Volume: 33, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Cycle; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Models, Chemical; Propidium; Ribonucleotide Reductases; Stilbenes; Time Factors

2008
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
    Experimental cell research, 2010, Jan-01, Volume: 316, Issue:1

    Topics: CD11b Antigen; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Chromatin Immunoprecipitation; DNA; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Granulocyte Precursor Cells; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Promyelocytic, Acute; Neutrophils; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-vav; RNA, Small Interfering; Stilbenes; Syk Kinase; Trans-Activators; Tretinoin

2010
Vav promotes differentiation of human tumoral myeloid precursors.
    Experimental cell research, 2005, May-15, Volume: 306, Issue:1

    Topics: Cell Cycle Proteins; Cell Differentiation; Cell Line, Tumor; Enzyme Inhibitors; Gene Expression; Gene Expression Regulation, Leukemic; Granulocytes; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Myeloid Progenitor Cells; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-vav; RNA, Small Interfering; Stilbenes; Transfection; Tretinoin; Tumor Cells, Cultured

2005